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The path from retrovirus to cellular oncogene is a com- forkhead (fkh), refers to the phenotype of mutants that
mon one. All retroviral oncogenes are derived from the show homeotic transformations in the anterior and poste-
genome of the host cell. They are mutated and assimi- rior gut with head-like structures at both ends of the
lated into the viral genome. Their replication, expression, embryo (Weigel et al., 1989). The developmental regula-
and movement into new cells are all under viral control tor hepatocyte nuclear factor 3b (HNF-3b) was one of
(for reviews see Bishop, 1983; Varmus, 1984). As geneti- the first WH proteins identified in mammals (Lai et al.,
cally altered captives, they reveal latent properties that 1991). It is highly expressed in the node, notochord, floor
are not evident in their cellular progenitors. The qin gene plate, and endoderm of the mouse embryo. HNF-3b null
is a recent example, discovered as a cell-derived onco- mutations cause embryonic lethality with defects in node
genic determinant in avian sarcoma virus 31 (ASV 31) (Li and notochord formation (Ang and Rossant, 1994;
and Vogt, 1993). The genome of ASV 31 is similar to that Weinstein et al., 1994). More than half a dozen WH genes
of other defective transforming retroviruses (Fig. 1). Part have now been analyzed by germ line knockouts, and all
of the viral gag and all of the pol region are missing and of these show informative phenotypes (Ang and Rossant,
replaced by the qin insert that is expressed as a Gag – 1994; Dou et al., 1997; Hatini et al., 1996; Labosky et al.,
Qin fusion protein. The qin or gag–qin sequences ex- 1997; Weinstein et al., 1994; Winnier et al., 1997; Xuan
cised from the ASV 31 genome and inserted into the et al., 1995). A very familiar example of a developmentally
retroviral expression vector RCAS show the same onco- important WH gene is the nude mouse, whose immuno-
genic potential as the native ASV 31. Therefore, qin func- logical deficiencies and lack of hair result from a muta-
tions as the oncogenic determinant of ASV 31; it is its tion in the whn gene that codes for a WH transcription
oncogene (Chang et al., 1996; Li and Vogt, 1993). factor (Nehls et al., 1994).
Qin codes for a protein that belongs to the winged Qin is the homolog of the mammalian brain factor 1
helix family of transcription factors. The hallmark of this (BF-1). The expression of BF-1 is restricted to the telen-
family is a conserved DNA binding domain, about 100 cephalon, the nasal half of the retina, and the optic stalk
amino acids in length (Lai et al., 1993; Kaufmann and (Tao and Lai, 1992). In the developing chicken embryo
Kno¨chel, 1996). One of the three a helixes in this domain expression of Qin is also confined to the telencephalon
makes contacts with the major groove of double- (Chang et al., 1995). Mice with null mutations of BF-1 die
stranded DNA. These contacts are stabilized by adjacent at birth with severe defects in the development of the
loop structures that also interact with the DNA, hence cerebral hemispheres (Xuan et al., 1995). BF-1 is thought
the term ‘‘winged helix’’ (WH) (Brennan, 1993; Clark et al., to control the replication of cortical progenitor cells, but
1993). Outside the DNA binding domain, WH proteins the mechanism of this regulation is not understood
show considerable diversity of sequence and structure. (McConnell, 1995). Overexpression of Qin from a retrovi-
They function prominently as determinants of organ de- ral vector in the developing avian retina distorts the visual
velopment and tissue differentiation (Costa, 1994). The projection map on the optic tectum, presumably by in-
prototype gene coding for a WH protein was discovered terfering with normal mechanisms of axon guidance (Yu-
during developmental studies in Drosophila; its name, asa et al., 1996). Recently described continuous cell lines
of murine neocortical neuroblasts show high expression
of BF-1 (Chun and Jaenisch, 1996). Although these obser-
1 To whom correspondence and reprint requests should be ad- vations and data on the role of BF-1/Qin are incompletedressed. Fax: (619) 784-2070. E-mail: pkvogt@scripps.edu.
and fragmentary, they are clear indicators that we are2 Current address: Department of Hematology/Oncology, University
of Freiburg, Hugstetter Strasse 55, 79106 Freiburg, Germany. dealing with an important control element in brain devel-
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and reporter plasmids carry GAL4 binding sites. Deletion
of the GAL4 target sequences on the reporter then abol-
ishes Qin-induced transcriptional repression. Binding to
DNA is therefore required for this repression effect,
which may be caused by competition with an activator
FIG. 1. Map of the ASV 31 genome. Dgag and env represent viral for the same DNA binding site, by a protein–protein inter-
coding sequences of the genes for internal structural proteins and action of Qin with a transcriptional activator (quenching),
envelope proteins, respectively. Qin is a cell-derived insert that re-
or by an interaction of Qin with a component of the basicplaces the 3* portion of the gag and all of the pol gene. LTR, long
transcriptional machinery (direct repression). The latterterminal repeat; UTR, untranslated region.
two mechanisms require a specific repressor domain
separate from the DNA binding domain. Such a domain
has been identified in Qin; like the repressor domains ofopment. Further experiments on BF-1/Qin in embryogen-
esis will be both interesting and challenging and will some known direct repressor proteins, it is rich in ala-
nines. v-Qin is a stronger repressor than c-Qin, whichhelp us understand the oncogenicity of the gene.
The viral Qin protein (v-Qin) differs from its cellular appears paradoxical considering its reduced affinity for
DNA (Li et al., 1997). However, an inverse relationshipcounterpart both structurally and functionally (Chang et
al., 1995; Li et al., 1997) (Fig. 2). Its amino terminus is between DNA binding and transcriptional repression is
not unique for Qin. It has been observed with other re-fused to Gag sequences with an eight-amino-acid linker,
probably of cellular origin. v-Qin is also truncated at the pressors, for instance Drosophila Even-skipped (Han and
Manley, 1993). One suggested explanation for this factcarboxyl terminus by a premature stop codon, and the
last eight amino acids of v-Qin are not homologous to is that the repressor binds its DNA target and then con-
tacts a component of the transcription initiation complex,cellular Qin (c-Qin). In addition, the coding sequence of
v-Qin shows two nonconservative amino acid substitu- thus interfering with transcription. The interaction be-
tween repressor and transcriptional machinery is facili-tions: a G to D substitution in the DNA binding domain
and an S to N substitution near the amino terminus in a tated by a dissociation of repressor and DNA (Han and
Manley, 1993).presumed transcription regulatory region.
Both c-Qin and v-Qin proteins, expressed from the ret- Transcriptional repression and oncogenic transforma-
tion have been mapped by deletion analysis to overlap-roviral vector RCAS, stimulate the growth of chicken em-
bryo fibroblasts (CEF), inducing the formation of trans- ping domains in Qin: both activities depend on (in addi-
tion to the intact WH region) sequences in the carboxyl-formed cell foci and of agar colonies in cell culture (Li
et al., 1997). v-Qin is also highly tumorigenic in the animal terminal third of the molecule (Li et al., 1995). This
colocalization of repression and transformation domainsin contrast to c-Qin, which causes tumors in only a small
fraction of the injected animals and only after a prolonged suggests a possible role of transcriptional repression
in oncogenicity. The suggestion is strengthened by thelatent period (Li et al., 1997). It is possible that these rare
c-Qin-induced tumors arise as a result of mutations in properties of chimeras in which the carboxyl-terminal
repression domain of Qin has been replaced either withthe oncogene that is being expressed from an actively
replicating and mutation-prone retroviral vector. Qin pro- the transactivation domain of the herpes simplex virus
protein VP16 or the repression domain of the Drosophilateins are localized in the nucleus (Li and Vogt, 1993).
They bind to the consensus sequence TGTAAACAAA. c- protein Engrailed (Poole et al., 1985; Triezenberg et al.,
1988). Qin–Engrailed chimeras function as repressors;Qin binds to this target sequence with far greater affinity
than v-Qin (Li et al., 1995). The difference has been they transform CEF in cell culture and induce tumors
in the animal. Qin–VP16 chimeras activate transcriptionmapped to the G to D substitution in the DNA binding
domain. This mutation seems to weaken v-Qin DNA inter- from Qin binding sites; they are not oncogenic in vitro or
in vivo. The cells expressing Qin–VP16 are flat and highlyaction in general, because it has not been possible to
identify a variant high-affinity target sequence of v-Qin
by PCR selection. A D to G substitution introduced onto
a v-Qin background makes the protein less oncogenic
in the animal. The fact that tumor production by this point
mutation is reduced but not abolished suggests that
other mutations present in v-Qin contributes to oncoge-
nicity (Li, Chang, Thurm, and Vogt, 1996, unpublished
observation).
FIG. 2. c-Qin and v-Qin proteins compared. v-Qin is fused to GagIn transient transfection tests with a luciferase reporter
via a cell-derived seven-amino-acid linker. It has two amino acid substi-
carrying six Qin binding sites, both Qin proteins function tutions: a S r N in the amino-terminal half and a G r D in the DNA-
as repressors (Li et al., 1995). Repression is also ob- binding region. WHD, winged helix domain; RTD, repression and trans-
formation domain.served if Qin is linked to the GAL4 DNA binding domain
AID VY 8846 / 6a53$$$$$2 10-15-97 09:36:31 vira AP: VY
3RETROVIRAL QIN AND WH PROTEIN ONCOGENICITY
adherent, and they show a 10- to 50-fold resistance to
transformation with v-Qin.
The correlation between transcriptional repression
and oncogenicity and the colocalization of transforming
and repression domains on the genetic map of Qin sug-
gest that Qin induces oncogenic transformation by down-
regulating the expression of specific genes. Determining
the identity and function of these genes remains a major
and urgent task for the future. In general terms, direct
Qin targets that control the oncogenic phenotype of the
cell would have to be negative growth regulators and
thus tumor suppressor genes. Two of the possible mech-
FIG. 3. Fusion of PAX3 and FKHR resulting from the recurrent t(2;13)anisms of Qin-dependent transcriptional repression,
translocation in alveolar rhabdomyosarcoma. WHD, winged helix do-quenching and direct repression, require protein–protein
main; PB, paired box; HD, homeodomain. The fusion protein retainsinteractions between Qin and either an activator protein the DNA binding domain of PAX3 but not that of FKHR. The carboxy-
or a component of the transcription initiation complex. terminal portion of FKHR may contain a strong transactivation domain.
Defining and characterizing these interactions is a sec-
ond important challenge for the future.
Numerous WH proteins have been described over the CWH-1, CWH-2, and CWH-3 proteins from the replication-
competent retroviral vector RCAS induces changes inpast 6 years (Kaufmann and Kno¨chel, 1996), and it is
reasonable to assume that Qin is not the only one that morphology and growth pattern of CEF (Freyaldenhoven
et al., 1997a). CWH-1 and CWH-3 stimulate anchorage-has latent oncogenic properties. Since transcription fac-
tor oncogenes (with the only exception of fos) are much independent growth and cause increased saturation
density of CEF. Wildtype CWH-2 is less growth stimula-more effective in transforming avian than mammalian
cells, a search for oncogenic WH proteins commenced tory, but can mutate to induce foci of transformed cells
(Vogt, 1997, unpublished observation). These results sug-with the chicken genome. The cDNA clones ‘‘chicken
winged helix (CWH) 1, 2, and 3’’ were isolated from a gest that the potential to stimulate abnormal cell prolifer-
ation is common among WH proteins.chicken embryonic cDNA library by low-stringency hy-
bridization using the sequence that codes for the c-Qin Similar to Qin, CWH-1, CWH-2, and CWH-3 function
as transcriptional repressors in CEF, either as wildtypeDNA binding domain as a probe (Freyaldenhoven et al.,
1997a). Comparison with the genetic sequence database proteins acting on a reporter with a Qin binding site or
as GAL4 fusion products acting on a reporter containingshowed CWH-1 to be most closely related to mouse brain
factor 2 (BF-2) and to its rat homolog HFH-B2 (Clevidence GAL4 binding sites (Freyaldenhoven et al., 1997b). The
strongest repressor in these tests is CWH-3. Its repres-et al., 1993; Hatini et al., 1994). It is also closely related
to the human gene termed forkhead-related activator 4 sion domain was mapped to a 96-amino-acid sequence
in the carboxyl-terminal third of the protein. This region(FREAC-4) (Pierrou et al., 1994). CWH-2 is most likely the
chicken homolog of the mouse mesenchyne forkhead is homologous to the repression domain of Qin in posi-
tion and amino acid composition. Both repression do-protein MFH-1 (Miura et al., 1993). CWH-3 shares signifi-
cant homology with the rat HNF-3/fkh homolog HFH-2 mains share a high content of proline or alanine resi-
dues, which are characteristic features of repression(Clevidence et al., 1993) and with a recently identified
mouse winged helix factor Genesis (Sutton et al., 1996). domains found in prototypical direct transcription repres-
sors (Cowell, 1994; Hanna-Rose and Hansen, 1996). TheAll three CWH proteins show tissue-specific expression
by Northern blot analysis. CWH-1 mRNA is found in em- role of transcriptional repression in the growth regulatory
activities of CWH-1, CWH-2, and CWH-3 remains to bebryonic brain, with weaker signals in intestine and kid-
ney. CWH-2 mRNA is detectable in embryonic and adult determined.
Oncogenic WH proteins have been uncovered by yetbrain and kidney. CWH-3 mRNA is restricted to embry-
onic lung and intestine and is not detectable in adult another line of investigation: the study of chromosomal
rearrangements that occur with high regularity and fre-tissues. In CEF, CWH-1 and CWH-2 but not CWH-3
mRNAs are observed. quency in certain human cancers, notably leukemias,
lymphomas and some solid tumors. In pediatric alveolarIn electrophoretic mobility shift assays, the CWH pro-
teins bind with different affinities to two conserved DNA rhabdomyosarcoma, a recurrent t(2;13)(q35q14) translo-
cation generates a chimeric product that contains thebinding sites for WH proteins, the B2 site in the HNF-
1 promoter (Kuo et al., 1992) and the Qin binding site amino-terminal portion of the PAX3 protein fused to the
carboxyl-terminal region of the winged helix protein(Freyaldenhoven et al., 1997b; Li et al., 1997). CWH-1
and CWH-2 also bind to the TTR site in the transthyretin FKHR (Barr et al., 1993; Galili et al., 1993; Shapiro et al.,
1993) (Fig. 3). In this fusion product, FKHR is truncatedpromoter (Costa et al., 1989). Overexpression of wildtype
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within the winged helix domain, but still contains a puta- would normally eliminate some of these embryonic cell
lineages.tive transactivation domain at its carboxyl terminus. The
PAX3-derived portion encompasses the intact paired box The second winged helix transcription factor shown to
be rearranged in human cancer is AFX. It was found asand homeodomains and provides the sequence-specific
DNA binding function of the fusion protein. A variant a fusion partner of the MLL gene (also referred to as ALL
or HRX). The fusion results from t(X;11)(q13q23) translo-t(1; 13)(p36q14) chromosomal translocation found in a
subset of alveolar rhabdomyosarcomas fuses the amino- cations in acute lymphocytic leukemia and in nonlympho-
blastic leukemia (Borkhardt et al., 1997; Corral et al.,terminal portion of the PAX7 protein to the same carboxyl-
terminal FKHR fragment as in the prevalent t(2;13) trans- 1993; McCabe et al., 1994; Parry et al., 1994). The MLL
gene maps to q23 on chromosome 11. It participateslocation (Biegel et al., 1991; Douglass et al., 1991; Whang-
Peng et al., 1992). Again, DNA binding is determined by in numerous diverse translocations in acute leukemias
(Rabbitts, 1994; Rowley, 1993). In these rearrangements,the PAX component (Davis et al., 1994). The FKHR gene
contains three exons (Davis et al., 1995). Exon 1 extends the 5* region of MLL is fused with different partner genes,
some of which have been identified and genetically char-to and includes the amino-terminal region of the winged
helix domain. The carboxyl-terminal region of the winged acterized (McCabe et al., 1992; Parry et al., 1993; Rowley,
1993). MLL fusion partners commonly contain structuralhelix domain and a transcriptional activation domain are
encoded by exon 2, while exon 3 consists of the 3* un- motifs that are also seen in transcriptional regulators
such as zinc-fingers and leucine-zippers in the AF10 andtranslated region. The boundary between intron 1 and
exon 2 coincides with the FKHR fusion point in the chime- AF17 genes or in nuclear targeting sequences in AF4
(Chaplin et al., 1995; Nakamura et al., 1993; Prasad etric transcripts found in alveolar rhabdomyosarcomas
(Davis et al., 1995). PAX3 and PAX7 proteins code for al., 1994). The MLL protein is related to the trithorax
protein of Drosophila. The two show high homology intranscriptional regulators that control developmental pro-
grams. They share similar expression patterns in the their carboxyl-terminal portion and share similar zinc-
finger motifs (Djabali et al., 1992; Gu et al., 1992; Tkachukdeveloping nervous system as well as in the developing
somites of the mammalian embryo around the time of et al., 1992). The AFX gene is homologous to the FKHR
winged helix transcription factor of human alveolar rhab-dermomyotome formation (Bober et al., 1994; Chalepakis
et al., 1993; Goulding et al., 1991, 1994; Jostes et al., domyosarcoma (Borkhardt et al., 1997). The fusion point
in the MLL–AFX1 protein is at the same amino acid1991; Williams and Ordahl, 1994). PAX3 expression oc-
curs prior to myoblast migration and formation of the position within the winged helix domain as in the PAX3–
FKHR fusion, rendering the DNA binding domain of AFX1musculature; PAX7 expression begins a few days later
and is maintained during the differentiation of the trunk nonfunctional (Parry et al., 1994). The AFX protein con-
tains some potentially interesting motifs, including a hex-and limb muscles. Both PAX3 and the PAX3–FKHR fusion
protein can prevent myogenic differentiation of cultured apeptide that is highly homologous to one seen in Hox
proteins, where it mediates cooperative DNA binding ofmyoblast cells (Epstein et al., 1995). Compared to PAX3,
the fusion product PAX3–FKHR is a stronger activator the Hox–Pbx complex. This hexapeptide is missing in the
MLL–AFX1 fusion product. The biochemical functions ofof transcription and inhibitor of myogenic differentiation
(Fredericks et al., 1995). Overexpression of the PAX3– the MLL–AFX protein remain to be determined.
v-qin functions as a dominantly acting oncogene, andFKHR fusion protein from the retroviral RCAS vector in-
duces morphological transformation and anchorage-in- the fusion genes PAX3–FKHR and MLL–AFX may play
a similar role in human cancer. v-qin and PAX3–FKHRdependent growth of CEF in culture. Wildtype PAX3 ex-
pressed from the same vector does not transform CEF have properties of transcriptional regulators. They bind
sequence specifically to DNA and stimulate or repress(Scheidler et al., 1996). The fact that the PAX3–FKHR
protein is a more potent transcriptional activator than the transcription of reporter genes. They may, therefore,
induce oncogenic transformation by aberrant positive orwildtype PAX3 suggests that the transforming activity of
the fusion protein may reflect a gain of activating function negative regulation of specific target genes. Although the
precise mechanism of action for MLL–AFX remains to beon PAX3 targets. Downregulation of the PAX3–FKHR fu-
sion gene product in alveolar rhabdomyosarcoma cells worked out, this fusion product also contains elements of
a transcriptional regulator. Transcriptional regulators areby antisense oligonucleotides induces cellular apoptosis
(Bernasconi et al., 1996). themselves controlled at transcriptional and posttran-
scriptional levels. All WH proteins studied so far showThese data suggest that the PAX–FKHR fusions may
act as dominant oncogenes responsible for the initiation characteristic developmental stage- and tissue-specific
expression. Little is known about the upstream signalsand maintenance of the neoplastic phenotype in alveolar
rhabdomyosarcoma cells. They may aberrantly regulate that are in charge of these expression patterns.
The oncogenicity of WH proteins is part of a broaderthe transcription of PAX target genes, and this differential
regulation of gene expression may result in tumor forma- problem, the oncogenicity of transcriptional regulators in
general. The important questions are the same through-tion, perhaps by suppressing an apoptotic program that
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molecular cloning of the t(10;11) translocation in acute leukemia.out this field, i.e., identification of downstream target
Blood 85, 1435–1441.genes and their function in inducing the oncogenic cellu-
Chun, J., and Jaenisch, R. (1996). Clonal cell lines produced by infection
lar phenotype, characterization of protein–protein inter- of neocortical neuroblasts using multiple oncogenes transduced by
actions that stimulate or inhibit the transcriptional ma- retroviruses. Mol. Cell. Neurosci. 7, 304–321.
Clark, K. L., Halay, E. D., Lai, E., and Burley, S. K. (1993). Co-crystalchinery, and clarification of upstream signals that control
structure of the HNF-3/fork head DNA-recognition motif resemblesthe transcriptional regulator. The technical advances in
histone H5. Nature 364, 412–420.the isolation of differentially expressed genes and in the
Clevidence, D. E., Overdier, D. G., Tao, W., Qian, X., Pani, L., Lai, E., and
detection of protein–protein interactions continue to be Costa, R. H. (1993). Identification of nine tissue-specific transcription
rapid and promise to yield insights into both viral and factors of the hepatocyte nuclear factor 3/forkhead DNA-binding-
domain family. Proc. Natl. Acad. Sci. USA 90, 3948–3952.nonviral oncogenesis mediated by aberrant transcrip-
Corral, J., Forster, A., Thompson, S., Lampert, F., Kaneko, Y., Slater, R.,tional control (Aronheim et al., 1997; Lavery et al., 1997;
van der Schoot, C. E., Ludwig, W. D., Pocock, C., Cotter, F., and Rab-Shalon et al., 1996).
bits, T. H. (1993). Acute leukemias of different lineages have similar
MLL gene fusions encoding related chimeric proteins resulting from
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